학술논문
Optimization of dose and route of administration of the P-glycoprotein inhibitor, valspodar (PSC-833) and the P-glycoprotein and breast cancer resistance protein dual-inhibitor, elacridar (GF120918) as dual infusion in rats
Document Type
Article
Author
Source
In: Pharmacology Research and Perspectives . (Pharmacology Research and Perspectives, April 2021, 9(2))
Subject
Language
English
ISSN
20521707